Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Children (Basel, Switzerland)|February 25, 2023
Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children's Hospital: A Contribution to a Still Inadequate Body of EvidenceAntonio Arrieta, Alvaro E Galvis, Stephanie Osborne, et al.
Children (Basel, Switzerland)|March 28, 2025
Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well ToleratedDelma J Nieves, M Tuan Tran, Jasjit Singh, et al.
The Pediatric Infectious Disease Journal|January 23, 2023
Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical TrialEmmanuel Roilides, Negar Ashouri, John S Bradley, et al.
Open Forum Infectious Diseases|June 11, 2021
Invasive <i>Mycobacterium abscessus</i> Outbreak at a Pediatric Dental ClinicJasjit Singh, Kathleen O'Donnell, Delma J Nieves, et al.
The Lancet. Child & Adolescent Health|October 29, 2021
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trialJane C Burns, Samantha C Roberts, Adriana H Tremoulet, et al.
The Journal of Infectious Diseases|December 12, 2018
Blood Viral Load in Symptomatic Congenital Cytomegalovirus InfectionConcetta Marsico, Immaculada Aban, Huichien Kuo, et al.
Archives of Disease in Childhood|March 7, 2020
Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnessesShiying Hao, Xuefeng B Ling, John T Kanegaye, et al.
The Journal of Infectious Diseases|December 12, 2012
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenzaDavid W Kimberlin, Edward P Acosta, Mark N Prichard, et al.
Contemporary Clinical Trials|March 7, 2019
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki diseaseSamantha C Roberts, Sonia Jain, Adriana H Tremoulet, et al.
The New England Journal of Medicine|March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus diseaseDavid W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Pageof 2